Asia-Pacific Seasonal Influenza Vaccines Market to Surpass $1.7 Billion by 2022: Decentralized Vaccine Policy & Reimbursement ...
Dublin, Feb. 07, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Seasonal Influenza Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Elderly Population, Growing Awareness and Launch of …